Potential new contender in AF
31 August 2009
| by Nicola Garrett
A high dose of the direct thrombin inhibitor dabigatran is more effective in preventing strokes and peripheral embolic events in patients with atrial fibrillation (AF) than warfarin, results of a large randomised trial show....
Want to read complete article? Please Sign in or Register.